The market size for the GLP-1 diabetes treatment drugs market is projected to reach USD 62,543.2 million by 2035
Pharmacokinetic Analysis in MC38 Syngeneic Model [1] MedChemExpress (MCE) has not independently confirmed the accuracy of these methods
Studies show that the consumption of higher quantities of caffeine during the day puts people at risk for insomnia and sleep disruptions during the night
In this episode of On The Pen, Dave Knapp sits down with obesity medicine expert Angela Fitch to break down exactly who qualifies, how to apply, which medications are covered, and what this historic expansion of obesity treatment access means for patients across America
Want access to multiple medication options: If you and your clinician want the flexibility to choose from branded GLP-1 injectables, oral options, non-GLP-1 medications, and compounded alternatives under one clinical umbrella, Found Health describes a wide range of medication options within its program
